Lung Disease Complicates RA Care - Summary - MDSpire
Advertisement
Lung Disease Complicates RA Care
Patients with chronic lung disease had numerically lower remission rates and substantially more serious adverse events in a 5-year Japanese registry study of late-onset rheumatoid arthritis.
To evaluate the long-term outcomes of a treat-to-target strategy in patients with late-onset rheumatoid arthritis (RA) and chronic lung disease (CLD), highlighting its significance in improving patient care.
Key Findings:
29.8% of patients with CLD achieved remission compared to 44.0% without CLD (not statistically significant).
Functional status was achieved by 36.2% of patients with CLD versus 45.3% without CLD (not statistically significant).
Patients with CLD experienced more treatment-related limitations and serious adverse events, indicating a need for careful management.
Interpretation:
Patients with CLD had consistently worse outcomes compared to those without CLD, although differences were not statistically significant. The study suggests that tighter disease control may influence pulmonary outcomes, warranting further investigation.
Limitations:
Study was observational and nonrandomized, conducted at a single center, which may limit generalizability.
Small CLD subgroup and significant attrition over 5 years could affect the robustness of findings.
Potential underrecognition of mild lung disease due to inconsistent testing may skew results.
Conclusion:
Further evidence is needed to manage ILD and serious adverse events in late-onset RA patients with CLD when implementing treat-to-target strategies, emphasizing the importance of ongoing research.
